influenza virus in a mouse model. Interestingly, PD1 levels were reduced during infection, and the levels of reduction correlated with virulence and disease. Importantly, exogenous administration of PD1 ameliorated lung function during infection, reduced viral titers, and increased survival. Consistent with these data, ablation of the host enzyme 12/15-lipoxygenase (12/15-LOX) responsible for PD1 synthesis increased viral replication and disease. Tam et al. (2013) also conducted a comprehensive analysis of lipid mediators during influenza virus infection in mouse lungs, comparing two viruses of high and low virulence. This analysis was integrated with data on cytokine and chemokine profiles, virus replication, and transcriptomics. Interestingly, the authors also identified lipid metabolites derived from the 12/15-LOX pathway as differentially regulated by infection according to virulence. In the mouse, 12/15-LOX derived metabolites were elevated during resolution of infection with the less-virulent virus. Intriguingly, levels of 12-LOX generated metabolites also correlated with increasing clinical symptoms in nasal washes from influenza-virus-infected humans. Moreover, the ratios of two other lipid metabolites, the proinflammatory 9 HODE and the anti-inflammatory 13 HODE, were found to be predictive of the level of inflammation, at least in the mouse model.
Although PD1 levels were not detected in the study by Tam et al., data from both studies are consistent with a protective role of 12/15 LOX-derived metabolites. More detailed studies will be needed in humans to validate the use of these metabolites for the treatment of influenza. However, the identification of lipid mediators that directly inhibit virus replication while at the same time promoting resolution of inflammation due to their antiinflammatory properties provides the basis for an interesting new concept for the treatment of influenza. Other immunoregulatory molecules might indirectly increase viral replication by inhibiting antiviral inflammatory effectors, and a right balance between beneficial effects related to their anti-inflammatory properties and detrimental effects due to potential increased viral replication during reduced inflammation might be difficult to achieve. By combining direct antiviral activity with anti-inflammatory properties, bioactive lipid mediators such as PD1 are attractive candidates for the development of new drugs for the treatment of influenza and perhaps of other viral diseases characterized by high viral replication in the context of exacerbated proinflammatory responses (Figure 1 ). Because this strategy targets host factors involved in viral replication rather than viral proteins, it is unlikely to be easily overcome by the selection of resistant mutant viruses.
Large-scale screens to identify protein interactions typically underperform with eukaryotic extracellular proteins. In this issue, Ö zkan et al. report development of a high-throughput assay designed specifically for extracellular proteins that uncovers a wealth of new interactions among three protein superfamilies in Drosophila and sets the stage for more extensive screens.
The metazoan genome sequences that began appearing in the late 1990s spawned an ''omics'' era in which large arrays of gene products could be screened for function in an automated, high-throughput fashion. Yeast twohybrid and affinity purification massspectrometric analyses proved particularly amenable to large-scale analyses of protein-protein interactions, and many interaction networks, known as interactomes, have been reported (Braun et al., 2009; Guruharsha et al., 2011; Miller et al., 2005; Yu et al., 2008) . Extracellular and transmembrane proteins turn out to be difficult to characterize by these methods, however, owing to difficulties with their expression, solubilization, and the inherently weak nature of many extracellular interactions when not multivalent or concentrated within a cell membrane. As a result, reliable global interaction data for extracellular proteins have lagged that are available for intracellular proteins (Braun et al., 2009) .
In this issue of Cell, Ö zkan, Garcia, and colleagues have now stepped into this breach by developing a high-throughput assay, which they term the Extracellular Interactome Assay (ECIA), specifically designed to screen for interactions between extracellular proteins (Ö zkan et al., 2013 ). To accomplish this task, ''bait'' and ''prey'' proteins are expressed in Drosophila S2 cells, the former as an N-terminal fusion protein with the dimeric F c region of immunoglobulins and the latter as an N-terminal fusion to alkaline phosphatase (AP) and the pentameric helical region of cartilage oligomeric matrix protein (COMP). Use of S2 cells takes advantage of these cells' chaperone and glycosylation machineries, as well as the oxidizing environment of their secretory pathway to facilitate production of functional extracellular proteins. Fusing bait and prey proteins to oligomeric partners creates multivalent substrates that increase the avidity of what may be intrinsically weak interactions owing to the concentrating effects of the cell membrane. In the assay, the bait F c -fusion proteins in conditioned medium are adsorbed directly to Protein-A-coated plates, and interactions with prey proteins are detected by addition of conditioned medium containing AP-COMP fusion proteins. This strategy eliminates the need for individual purification steps and allows binding to be detected colorimetrically owing to the presence of AP activity in positive wells (Figure 1 ).
To inaugurate their assay, the authors focus on Drosophila proteins containing signal peptides (SPs) and immunoglobulin (Ig) domains, fibronectin type III (FNIII) domains, or leucine-rich repeats (LRRs). Members of these superfamilies are frequently involved in extracellular adhesion and receptor-ligand interactions, but binding partners for many remain unknown. Bioinformatics searches identified 202 Drosophila proteins meeting these criteria, most also containing a single transmembrane (TM) helix. This cohort represents 6% of Drosophila proteins with SPs, suggesting that scaling the assay to encompass nearly all possible interactions is feasible. Genes encoding each of these proteins were assembled, cloned into appropriate expression vectors, and 42,025 potential interactions representing 20,503 unique pairs assayed (each interaction was tested twice with bait/prey roles reversed). 106 unique interactions were observed, 86 heterophilic and 20 homophilic, and, in a stunning validation of the authors' efforts, 79 (92%) of the heterophilic and 4 (20%) of homophilic interactions were new. This success may of course be distorted by false positives, but several of these interactions were tested biochemically or with an in situ staining protocol. In each case, the interaction was validated, suggesting a low false-positive rate. Conversely, none of the 106 interactions observed here were present in published Drosophila interactome data sets (Yu et al., 2008) , and many of the 285 interactions for Ig, FNIII, and LRR proteins present in those earlier data sets seem unlikely to be physiological given that the putative interactors are neither cell surface nor extracellular proteins-highlighting the need for specialized assays to detect interactions between extracellular proteins.
Standing out among the new interactions uncovered by the ECIA are multiple connections between members of two pairs of Ig or Ig-FNIII superfamilies. In the first, 17 members of the 20 member Defective in Proboscis Extension Response (Dpr) family of 2-Ig domain, single-TM-containing proteins bind variously to 8 members of a previously uncharacterized 11 member family of 3-Ig, single-TM proteins named the DIP family by the authors for Dpr-Interacting Proteins. The dissociation constants for several pairs of Dpr-DIP proteins were determined by surface plasmon resonance and found to be in the micromolar range, which is common for extracellular interactions. AP-tagged Dprs display unique staining patterns in live-dissected wild-type and mutant Drosophila embryos that are consistent with their overlapping or nonoverlapping binding specificities as determined by the ECIA. In addition to these interfamily interactions, the LRRcontaining protein CG10824 was identified as a ''hub'' molecule that binds multiple Dprs and DIPs as well as additional proteins, 19 interactions in all. The presence of this hub molecule may provide clues to the functional evolution of Dprs and DIPs. As it stands, little genetic or functional information is available for either Dprs or DIPs, perhaps because of their high redundancy, although their apparent expression in neuronal tissues suggests roles in neuronal development and axon guidance.
The ECIA also uncovered interactions between a second pair of familiesthe 14 member, 2-Ig-containing ''Beat'' (named after the protein Beaten Path) and 8 member, (5-Ig)+(1-FNIII) ''Side'' (named after the protein Sidestep) families. Four different Beat proteins interact variously with seven different Side proteins. One of these interactions, between Sidestep and Beat-Ia, was previously described in the context of axon guidance (Siebert et al., 2009) , thus strengthening the connection between large families of Ig-domain-containing proteins and nervous system development.
In addition to combinatorial interactions between members of distinct protein families, several singular interactions were observed. Among these more idiosyncratic interactions, a particularly interesting connection was made between Vein, a Drosophila homolog of epidermal growth factor (EGF), and two related molecules, Ihog and Brother of Ihog, which are known to bind the Hedgehog protein and modulate its signaling. Many studies have connected Hedgehog and EGF signaling in both vertebrates and invertebrates (Mangelberger et al., 2012) , but this observation appears to be the first direct physical link between the two pathways, and it will be interesting to determine whether vertebrate EGF and Ihog homologs also interact.
Ö zkan et al. (2013) have clearly uncovered a bounty of interactions that will keep biologists busy for a long time. Happily, it is likely only the tip of the iceberg. With a few tweaks and additional automation, it is conceivable that the ECIA could be applied to much larger subsets of extracellular proteins, including, one hopes, all or most secreted proteins in key organisms. Although the authors found a false-negative rate of 50%, much of which could be attributed to poor expression of specific proteins, experience will likely iron out kinks and improve this number. Nonetheless, the current study of Drosophila proteins demonstrates that discovery of treasure troves of extracellular interactions awaits.
